Head-To-Head Analysis: Climb Global Solutions (NASDAQ:CLMB) and Nexalin Technology (NASDAQ:NXL)

Climb Global Solutions (NASDAQ:CLMB) and Nexalin Technology (NASDAQ:NXL) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

Valuation & Earnings

This table compares Climb Global Solutions and Nexalin Technology”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Climb Global Solutions	$652.52 million	0.65	$21.33 million	$1.14	19.86
Nexalin Technology	$300,000.00	29.57	-$8.22 million	($0.47)	-0.92

Climb Global Solutions has higher revenue and earnings than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than Climb Global Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Climb Global Solutions and Nexalin Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Climb Global Solutions	3.01%	20.43%	5.35%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

Institutional and Insider Ownership

49.7% of Climb Global Solutions shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 3.8% of Climb Global Solutions shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Climb Global Solutions has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.8, meaning that its share price is 280% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Climb Global Solutions and Nexalin Technology, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Climb Global Solutions	0	2	2	1	2.80
Nexalin Technology	1	0	0	0	1.00

Climb Global Solutions presently has a consensus price target of $31.00, indicating a potential upside of 36.93%. Given Climb Global Solutions’ stronger consensus rating and higher probable upside, research analysts clearly believe Climb Global Solutions is more favorable than Nexalin Technology.

Summary

Climb Global Solutions beats Nexalin Technology on 12 of the 15 factors compared between the two stocks.

About Climb Global Solutions

Climb Global Solutions Inc. operates as a value-added information technology (IT) distribution and solutions company in the United States, Canada, Europe, the United Kingdom, and internationally. It operates in two segments, Distribution and Solutions. The company distributes technical software to corporate and value-added resellers, consultants, and systems integrators under the name Climb Channel Solutions; and provides cloud solutions and resells software, hardware, and services under the name Grey Matter. It also resells computer software and hardware developed by others, as well as provides technical services to end user customers. In addition, the company offers a line of products from various software vendors; and tools for virtualization/cloud computing, security, networking, storage and infrastructure management, application lifecycle management, and other technically sophisticated domains, as well as computer hardware. It markets its products through its own web sites, local and on-line seminars, events, webinars, and social media, as well as direct email and printed materials. The company was formerly known as Wayside Technology Group, Inc. and changed its name to Climb Global Solutions Inc. in October 2022. Climb Global Solutions Inc. was incorporated in 1982 and is headquartered in Eatontown, New Jersey.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.